Lumiere Biologics

Introduction Lumiere Biologics is a multi-national corporation founded by one Dr. Hideki Ueda; a Japanese born naturalized American citizen. They own public patents for things like dietary supplements, diet pills, and prescription drugs, and their forte'... genetic Therapies for treating cancer... though they are a relatively new player in the field. Founding Date: June 27 1980 Lumiere Biologics was founded in 1980 by Dr. Hideki Ueda through the laws that allow legal residents of the United States to become entrepreneurs. The company was co-founded with his wife Dr. Maya Ueda shortly after their daughter Haruka was diagnosed with cancer. Hideki was a leader in the field of genetics, overcoming many of the still smoldering prejudices of the day to cement his position in the field. His wife, Maya, was American of Creole descent and was originally a Paleographer who specialized in Asian languages. She later showed her true colors as a multi-field genius when she became an accomplished bio-chemist in the years following their albino daughter's diagnosis of cancer at age 5. She never, however, lost her interest in languages and Paleography and was paid as a consultant for various Anthropological departments. [ edit ] Contacts Anisia - Why? That remains a mystery at this time, even she doesn't know. [ edit ] CEO C.E.O.: Dr. Hideki Ueda. He owns the most of the Class A shares, the company is his brainchild. (See Introduction Entry) [ edit ] CTO C.T.O.: Alan Everway. A grisled military veteran, Alan Everway is a CEO in his own right. With Lumiere Biologics he is the Chief Technical Officer (CTO). He heads the security company, Aegis Securities, which is a subsidiary of Lumiere Biologics. This company is under Lumiere Biologics's umbrella, funded and beholden to it and the vicissitudes of its shares, but it is its own security organization which has been employed in logistics support in Iraq and other world conflicts. They are a small player in that field, often recruiting from the Military and Police, but it has gained them a lot of favor with the U.S. State department. [ edit ] CFO C.F.O.: Elyse Mia Singh. Elyse is the Chief Financial Officer (CFO) for Lumiere Biologics. She is one of the younger members of the board at only 45 years old and is a talented financier who earned her reputation in some of Silicone Valley's startups. [ edit ]

Lumiere Biologics [ edit ] Overview Financial Profile: The Ueda Family, specifically Dr. Hideki Ueda, are Majority Shareholders of Lumiere Biologics's IPO, the shares are divided along lines of Class A and Class B shares with Class A shares equaling 10 votes to the value of 1 in the case of a Class B. Almost all of the control in the hands of the C.E.O. who remains invested in the daily activities. That said there is a board of directors which has been appointed to handle various facets of the company. [ edit ]